The Intercept is a left-wing, online newsroom that has been in business for a decade. It started in 2014 when its founders broke the story of Edward Snowden’s leaked government surveillance files, ...
Following a meeting with the FDA’s Gastrointestinal Drug Advisory Committee Friday, the future of Intercept’s rare liver disease drug Ocaliva is under serious threat. Looking to assess whether Ocaliva ...
The stock is exploding following an announcement that it's on track to be acquired. Alfasigma is poised to buy Intercept at a price of $19 per share. The deal stands a very good chance of being ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback